Identifying Genes That Affect Bortezomib Toxicity in Yeast
Author Information
Author(s): Takeda Kojiro, Mori Ayaka, Yanagida Mitsuhiro
Primary Institution: Okinawa Institute of Science and Technology (OIST), Okinawa, Japan
Hypothesis
We aimed to identify genes affecting the cytotoxicity of Bortezomib in the fission yeast S. pombe.
Conclusion
The study identified 19 genes whose deletions lead to strong synthetic lethality with Bortezomib, providing insights into the drug's mechanisms.
Supporting Evidence
- Bortezomib effectively inhibits the proliferation of S. pombe.
- 19 gene-deletion mutants were identified that showed severe growth defects with Bortezomib.
- 13 of the identified genes are conserved in humans.
Takeaway
Researchers found that certain genes in yeast make the drug Bortezomib more toxic, which helps us understand how the drug works.
Methodology
Genome-wide synthetic lethal screening was performed using a library of 2815 gene-deleted strains of S. pombe.
Limitations
The study is limited to findings in yeast, which may not directly translate to human biology.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website